EDIT — Editas Medicine Cashflow Statement
0.000.00%
Last trade - 00:00- $466.27m
- $143.16m
- $78.12m
- 25
- 23
- 36
- 18
Annual cashflow statement for Editas Medicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -134 | -116 | -193 | -220 | -153 |
| Depreciation | |||||
| Non-Cash Items | 24.3 | 34.4 | 45.1 | 28.6 | 16.6 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 65.9 | -102 | -21.4 | 8.18 | -1.59 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -40.7 | -180 | -164 | -177 | -132 |
| Capital Expenditures | -6.17 | -7.16 | -7.98 | -4.12 | -4.72 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 18.4 | -133 | -46.5 | 118 | 0.988 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 12.3 | -141 | -54.5 | 114 | -3.73 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 132 | 224 | 282 | 1.28 | 118 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 103 | -96.2 | 63.8 | -62 | -17.9 |